CO6362002A2 - Derivados de acido fenoxicroman carboxilico 6-sustituido - Google Patents

Derivados de acido fenoxicroman carboxilico 6-sustituido

Info

Publication number
CO6362002A2
CO6362002A2 CO11010027A CO11010027A CO6362002A2 CO 6362002 A2 CO6362002 A2 CO 6362002A2 CO 11010027 A CO11010027 A CO 11010027A CO 11010027 A CO11010027 A CO 11010027A CO 6362002 A2 CO6362002 A2 CO 6362002A2
Authority
CO
Colombia
Prior art keywords
fenoxychromic
carboxylene
substituted
acid derivatives
compounds
Prior art date
Application number
CO11010027A
Other languages
English (en)
Inventor
Laurence E Burgess
Christopher T Clark
Todd Romoff
Ganghyeok Kim
Kevin W Hunt
George Doherty
Robert Kirk Delisle
Christopher Corrette
Adam Cook
Original Assignee
Array Biopharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Array Biopharma Inc filed Critical Array Biopharma Inc
Publication of CO6362002A2 publication Critical patent/CO6362002A2/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
    • C07D311/20—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 hydrogenated in the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

Compuestos de la Fórmula Ien donde A1, A2, W, L, G, R7a, R7b, R8, R9 y R10 tienen las definiciones que se dieron en la memoria descriptiva, son moduladores de receptor de DP2 que son útiles en el tratamiento de enfermedades inmunológicas.
CO11010027A 2008-06-25 2011-01-28 Derivados de acido fenoxicroman carboxilico 6-sustituido CO6362002A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7561508P 2008-06-25 2008-06-25

Publications (1)

Publication Number Publication Date
CO6362002A2 true CO6362002A2 (es) 2012-01-20

Family

ID=40996727

Family Applications (1)

Application Number Title Priority Date Filing Date
CO11010027A CO6362002A2 (es) 2008-06-25 2011-01-28 Derivados de acido fenoxicroman carboxilico 6-sustituido

Country Status (33)

Country Link
US (4) US8569522B2 (es)
EP (3) EP2307397B1 (es)
JP (2) JP5753780B2 (es)
KR (1) KR101728175B1 (es)
CN (2) CN103450138B (es)
AR (1) AR072301A1 (es)
AU (1) AU2009262274B2 (es)
BR (1) BRPI0915513B8 (es)
CA (1) CA2729217C (es)
CL (1) CL2010001528A1 (es)
CO (1) CO6362002A2 (es)
CR (1) CR20110037A (es)
CY (1) CY1115650T1 (es)
DK (1) DK2307397T3 (es)
ES (2) ES2582161T3 (es)
HK (1) HK1155735A1 (es)
HR (1) HRP20140988T1 (es)
IL (2) IL210198A (es)
MX (1) MX2011000173A (es)
MY (2) MY161425A (es)
NZ (1) NZ590437A (es)
PH (1) PH12014500079A1 (es)
PL (1) PL2307397T3 (es)
PT (1) PT2307397E (es)
RS (1) RS53665B1 (es)
RU (1) RU2507200C2 (es)
SG (2) SG2014013544A (es)
SI (1) SI2307397T1 (es)
TW (2) TWI436990B (es)
UA (1) UA104867C2 (es)
UY (1) UY31938A (es)
WO (1) WO2009158426A1 (es)
ZA (1) ZA201100604B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009158426A1 (en) 2008-06-25 2009-12-30 Array Biopharma Inc. 6-substituted phenoxychroman carboxylic acid derivatives
JP5575799B2 (ja) * 2008-12-22 2014-08-20 アレイ バイオファーマ、インコーポレイテッド ７−フェノキシクロマンカルボン酸誘導体
EP2457900A1 (en) 2010-11-25 2012-05-30 Almirall, S.A. New pyrazole derivatives having CRTh2 antagonistic behaviour
TWI654180B (zh) 2012-06-29 2019-03-21 美商艾佛艾姆希公司 殺真菌之雜環羧醯胺
TW201507722A (zh) * 2013-04-30 2015-03-01 Bayer Cropscience Ag 做為殺線蟲劑及殺體內寄生蟲劑的ｎ－（２－鹵素－２－苯乙基）－羧醯胺類
WO2015126750A1 (en) 2014-02-19 2015-08-27 Array Biopharma Inc. BIOMARKERS PREDICTIVE OF RESPONSIVENESS TO TREATMENT WITH A CRTh2 INHIBITOR
CN111057003A (zh) * 2019-12-06 2020-04-24 广安凯特制药有限公司 一种立他司特中间体5,7-二氯-1,2,3,4-四氢异喹啉的合成方法
SE2151519A1 (en) * 2021-12-10 2023-06-11 Amidea Sweden Ab 2-(2,5-dimethoxyphenyl)ethanamine and uses thereof
CN114181039A (zh) * 2021-12-23 2022-03-15 凯美克(上海)医药科技有限公司 一种4,4-二苯基-3-丁烯-1-醇的合成方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5059609A (en) 1987-10-19 1991-10-22 Pfizer Inc. Substituted tetralins, chromans and related compounds in the treatment of asthma, arthritis and related diseases
US5006550A (en) * 1989-12-29 1991-04-09 Allergan, Inc. Chroman esters of phenols and benzoic acids having retinoid-like activity
US5952326A (en) 1997-12-10 1999-09-14 Pfizer Inc. Tetralin and chroman derivatives useful in the treatment of asthma, arthritis and related diseases
DE19850131A1 (de) * 1998-10-30 2000-05-04 Merck Patent Gmbh Chromenon- und Chromanonderivate
TR200103332T2 (tr) 1999-05-21 2002-04-22 Pfizer Products Inc. 1-Triflorometil-4-hidroksi-7-piperidinil-aminometilkroman türevleri.
CN102050758A (zh) * 2000-09-14 2011-05-11 田边三菱制药株式会社 酰胺衍生物及其制备药物的用途
WO2003029239A1 (en) * 2001-10-04 2003-04-10 Wyeth Chroman and benzofuran derivatives as 5-hydroxytryptamine-6 ligands
EA011087B1 (ru) * 2002-12-20 2008-12-30 Эмджен Инк. Соединения и фармацевтические композиции для лечения воспалительных заболеваний
CN101128423A (zh) * 2005-02-25 2008-02-20 伊莱利利公司 新型脂氧化酶抑制剂
GB0611781D0 (en) * 2006-06-14 2006-07-26 Argenta Discovery Ltd 2-Oxo-2H-Chromene Compounds
MX2009001876A (es) 2006-08-21 2009-03-06 Array Biopharma Inc Derivados de acido fenoxifenilacetico 4-sustituidos.
EP2079467B1 (en) * 2006-10-31 2015-11-18 Merck Sharp & Dohme Corp. Antidiabetic bicyclic compounds
US7960567B2 (en) * 2007-05-02 2011-06-14 Amgen Inc. Compounds and methods useful for treating asthma and allergic inflammation
WO2009061730A2 (en) 2007-11-05 2009-05-14 Array Biopharma Inc. 4-heteroaryl-substituted phenoxyphenylacetic acid
WO2009158426A1 (en) 2008-06-25 2009-12-30 Array Biopharma Inc. 6-substituted phenoxychroman carboxylic acid derivatives
JP5575799B2 (ja) * 2008-12-22 2014-08-20 アレイ バイオファーマ、インコーポレイテッド ７−フェノキシクロマンカルボン酸誘導体

Also Published As

Publication number Publication date
US20110105463A1 (en) 2011-05-05
JP2011526290A (ja) 2011-10-06
BRPI0915513B1 (pt) 2019-11-19
TW201022222A (en) 2010-06-16
KR101728175B1 (ko) 2017-04-18
TWI436990B (zh) 2014-05-11
WO2009158426A1 (en) 2009-12-30
IL241754A0 (en) 2015-11-30
DK2307397T3 (da) 2014-11-03
SG2014013528A (en) 2014-07-30
ES2582161T3 (es) 2016-09-09
EP2307397A1 (en) 2011-04-13
US20150232442A1 (en) 2015-08-20
MY185134A (en) 2021-04-30
ZA201100604B (en) 2015-08-26
US8716498B2 (en) 2014-05-06
RU2507200C2 (ru) 2014-02-20
MY161425A (en) 2017-04-14
BRPI0915513A2 (pt) 2016-01-26
CL2010001528A1 (es) 2011-07-01
CN103450138B (zh) 2015-04-08
EP3144303B1 (en) 2018-09-26
PH12014500079B1 (en) 2015-02-09
PT2307397E (pt) 2014-10-29
CA2729217C (en) 2016-09-06
US9556139B2 (en) 2017-01-31
HK1155735A1 (en) 2012-05-25
JP2014122241A (ja) 2014-07-03
RU2011102595A (ru) 2012-07-27
ES2524314T3 (es) 2014-12-05
HRP20140988T1 (hr) 2014-12-05
EP2826774B1 (en) 2016-05-25
US8569522B2 (en) 2013-10-29
AU2009262274A1 (en) 2009-12-30
CN103450138A (zh) 2013-12-18
CR20110037A (es) 2011-03-14
AR072301A1 (es) 2010-08-18
TWI476186B (zh) 2015-03-11
PH12014500079A1 (en) 2015-02-09
NZ590437A (en) 2012-07-27
SG2014013544A (en) 2014-07-30
SI2307397T1 (sl) 2014-11-28
IL241754A (en) 2017-02-28
BRPI0915513B8 (pt) 2021-05-25
CN102131794A (zh) 2011-07-20
IL210198A (en) 2015-10-29
MX2011000173A (es) 2011-06-20
US20140221342A1 (en) 2014-08-07
IL210198A0 (en) 2011-03-31
CN102131794B (zh) 2013-09-25
UY31938A (es) 2011-01-31
PL2307397T3 (pl) 2015-02-27
CY1115650T1 (el) 2017-01-04
EP2826774A1 (en) 2015-01-21
KR20110027798A (ko) 2011-03-16
TW201427965A (zh) 2014-07-16
CA2729217A1 (en) 2009-12-30
US20140005418A1 (en) 2014-01-02
JP5753780B2 (ja) 2015-07-22
AU2009262274B2 (en) 2013-08-01
RS53665B1 (en) 2015-04-30
EP2307397B1 (en) 2014-08-20
EP3144303A1 (en) 2017-03-22
UA104867C2 (uk) 2014-03-25
US9096567B2 (en) 2015-08-04

Similar Documents

Publication Publication Date Title
CO6362002A2 (es) Derivados de acido fenoxicroman carboxilico 6-sustituido
UY32926A (es) Compuestos como antagonistas de los receptores de ácido lisofosfatídico
ECSP15022555A (es) Novedosos derivados de bencimidazol como antagonistas de ep4
CO6480927A2 (es) Derivados de imidazolin-2-ona 1,3-disustituida como inhibidores de cyp17.
CO6620050A2 (es) Derivados de aminopirimidina como moduladores de la lrrk2
CO6331340A2 (es) Pirrolo-pirimidinas y pirrolo piridinas
DOP2014000115A (es) Uso de 4-fenil-piridinas sustituidas para la fabricación de medicamentos útiles en el tratamiento de enfermedades relacionadas con el receptor de nk1
ECSP12012065A (es) Derivados de pirazina y su uso en el tratamiento de trastornos neurológicos
EA201270467A1 (ru) Полициклические соединения в качестве антагонистов рецепторов лизофосфатидной кислоты
EA201201343A1 (ru) Производные 4-аминопиримидина и их действующее вещество как антагонисты аденозинового рецептора а
BR112013009395A2 (pt) derivados de quinazolin-4 (3h)-ona usados como inibidores da pi3 cinase
EA201170832A1 (ru) Пуриновые соединения
CR10243A (es) "bencimidazoles 2-sustituidos como modulares de receptor de androgeno selectivos"
MX338088B (es) Imidazoquinolinas y derivados de pirimidina como moduladores potentes de los procesos angiogenicos impulsados por el factor de crecimiento endotelial vascular (vegf).
ECSP109968A (es) Depsipéptidos cíclicos
EA201170294A1 (ru) Способы лечения реперфузионных повреждений
EA201101118A1 (ru) Фармацевтические композиции, включающие производные 2-оксо-1-пирролидина
GT201300125A (es) 1h-pirazol-5-olato sódico sustituido
EA201290808A1 (ru) Замещенные конденсированные производные имидазола, фармацевтические композиции и способы их применения
EA201270302A1 (ru) Безводные формы производных пиридина
UA107346C2 (en) Use of nifuratel to treat infections caused by atopobium species
UA109804C2 (xx) 2-метоксипіридин-4-ільні похідні
BRPI1008188A2 (pt) "derivados de 6-(6-nh-subistituído-triazolopiridazina-sulfanil) benzotiazóis e benzimidazóis: preparo, aplicação como medicamentos e utilização como inibidores de met"
EA200801678A1 (ru) Применение производных триазина для производства лекарственного средства, обладающего заживляющим или ангиогенным эффектом
ATE440600T1 (de) Substituierte benzimidazole zur behandlung der histomiasis

Legal Events

Date Code Title Description
FG Application granted